NCT05635110View on ClinicalTrials.gov

Evaluation of the Effects of Omeprazole and Rifampin on the Pharmacokinetics of VX-548 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

June 8, 2023

Study Completion Date

June 8, 2023

Conditions
Pain
Interventions
DRUG

VX-548

Tablets for oral administration.

DRUG

Omeprazole

Tablets for oral administration.

DRUG

Rifampin

Capsules for oral administration.

Trial Locations (1)

Unknown

CMAX Clinical Research, Adelaide

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY